title: Increasing incidence of mucormycosis in University Hospital, Belgium.
abstract: To determine why incidence of mucormycosis infections was increasing in a large university hospital in Belgium, we examined case data from 2000-2009. We found the increase was not related to voriconazole use but most probably to an increase in high-risk patients, particularly those with underlying hematologic malignancies.
authors.affiliation: Leuven University Hospitals, Leuven, Belgium.
authors.forename: Veroniek
authors.initials: V
authors.lastname: Saegeman
authors.forename: Johan
authors.initials: J
authors.lastname: Maertens
authors.forename: Wouter
authors.initials: W
authors.lastname: Meersseman
authors.forename: Isabel
authors.initials: I
authors.lastname: Spriet
authors.forename: Eric
authors.initials: E
authors.lastname: Verbeken
authors.forename: Katrien
authors.initials: K
authors.lastname: Lagrou
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000009:adverse effects; D001530:Belgium / Q000453:epidemiology; D002648:Child; D005260:Female; D019337:Hematologic Neoplasms / Q000150:complications; D006785:Hospitals, University; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009091:Mucormycosis / Q000453:epidemiology* / Q000209:etiology; D011743:Pyrimidines / Q000009:adverse effects; D012307:Risk Factors; D014230:Triazoles / Q000009:adverse effects; D065819:Voriconazole; D055815:Young Adult
chemical_list: D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole